Simple IMRT. Credit: Charlotte Coles
(Medical Xpress)—Research from the newly formed Cambridge Cancer Centre, a collaboration between the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cancer Research UK and others, could change how women with breast cancer are treated.
The study, by researchers from Addenbrooke's Hospital and the University of Cambridge led by Dr Charlotte Coles, found that women who received treatment with Intensity Modulated Radiation Therapy (IMRT) showed better overall cosmetic results compared to those given standard radiotherapy using only 2-dimensional (2D) planning. The study, which has been funded by the charity Breast Cancer Campaign and the NIHR Cambridge Biomedical Research Centre, was published in the Journal of Clinical Oncology.
For the study, the researchers analysed the radiotherapy treatment plans of 1145 patients with early breast cancer who had previously had breast-conserving surgery. Of these, 815 women (71%) were identified as potentially being able to benefit from IMRT, and were randomised to receive IMRT or standard radiotherapy. After five years from completion of radiotherapy, 654 women were followed up, 228 having received IMRT.
This study was specifically designed to look at possible improvement in the cosmetic result with IMRT. As expected, there was no difference in survival rates or chance of recurrence between the two treatments. Taking all cosmetic aspects into consideration, the overall cosmetic benefit was greater with IMRT, thanks to less damage to the breast tissue: 88% (197) of women had good or moderate cosmetic appearance after five years compared to 78% (179) who received the standard 2D radiotherapy. As well as halving the risk of poor cosmesis compared to standard 2D radiotherapy, IMRT also reduced the risk of developing marked skin telangiectasia, (dilated blood vessels appearing near the surface of the skin): 15% (35) compared to 24% (56) who received standard 2D radiotherapy.
Dr Charlotte Coles, a researcher at Addenbrooke's Hospital and Senior Faculty member of the Cambridge Cancer Centre, said: "We strongly believe that quality of life is important, as well as saving lives, and cosmetic results from radiotherapy have a real impact once treatment is finished. It's not trivial or a question of vanity. Poor cosmetic results can affect psychological wellbeing as well leaving a physical scar. It's a visible reminder to the woman that she has had cancer."
Radiotherapy aims to treat the whole breast with an even dose of radiation - too low a dose can lead to cancer coming back, and too high a dose can cause extensive damage to the skin and tissue, leading to visible side-effects that can also be painful. Unlike 2D breast radiotherapy, IMRT accounts for the shape of the breast in three dimensions so that the dose remains even across the breast.
In addition, IMRT has been shown to significantly reduce short term side effects (less weeping and peeling skin), compared to standard 2D breast radiotherapy.
All UK radiotherapy centres have the equipment to provide 3D radiotherapy and simple breast IMRT where appropriate. However, delivery of IMRT has been inconsistent. According to a recent audit one in five radiotherapy centres in the UK are not routinely using simple IMRT.
Baroness Delyth Morgan, Chief Executive of Breast Cancer Campaign said: "These practice changing results give out a clear message that where appropriate women must be given access to IMRT to get the best possible medical and cosmetic results from treatment. We know the technology is in place to deliver IMRT so let's not give women standard treatment if there is something better; women deserve more."
Professor Neil Burnet, Professor of Radiation Oncology at the University of Cambridge, said: "This is a landmark study, with major significance for women with breast cancer. It demonstrates the value to patients, and indeed society, of using modern radiotherapy technology."
Explore further: Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
Medical Xpress on facebook
Related Stories
Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
Apr 21, 2013
Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European ...
Breast conserving treatment with radiotherapy reduces risk of local recurrence
Sep 18, 2013
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcin ...
Studies confirm shorter radiotherapy course best option for women with breast cancer
Sep 18, 2013
The long-term results of the landmark START trials conclusively confirm that giving radiotherapy as a lower overall dose in fewer, higher doses over a shorter treatment time (hypofractionated) is at least as effective and ...
Despite hype, costly prostate cancer treatment offers little relief from side effects
Dec 13, 2012
Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a standard radiation ...
IMRT reduces risk of side effects in breast cancer patients
Mar 28, 2012
Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical Ra ...
Recommended for you
Functional disability high among newly diagnosed older breast cancer patients
7 hours ago
Many older women with newly diagnosed breast cancer have difficulty accomplishing daily tasks, and African-Americans seem to be disproportionately affected. Those are the findings of a new study published early online in ...
Eating, exercises improve diet after pharyngeal cancer Tx
Sep 20, 2013
(HealthDay)—Patients who maintain eating and a regimen of swallowing exercises during treatment for pharyngeal cancers have the highest rate of return to a regular diet following treatment, according to ...
Implications of very low risk prostate cancer assessed
Sep 20, 2013
(HealthDay)—The risk of adverse findings at surgery for men with very low risk (VLR) prostate cancer is significantly lower than for those with low risk (LR), according to research published in the October ...
Elvitegravir fixed combination in HIV: Lesser benefit for treatment-naive patients
Sep 20, 2013
The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (elvitegravir fixed combination, trade name: Stribild) has been approved in Germany since May 2013 for the treatment of adults infected ...
Watching tumors burst through a blood vessel
Sep 20, 2013
Cancer cells metastasize in several stages—first by invading surrounding tissue, then by infiltrating and spreading via the circulatory system. Some circulating cells work their way out of the vascular ...
Study provides big-picture view of how cancer cells are supported by normal cells in and near tumors
Sep 19, 2013
Investigators at Cold Spring Harbor Laboratory (CSHL) today report important progress in research aimed at finding ways to fight cancer by targeting the local environment in which tumors grow and from which ...
User comments
© Medical Xpress 2011-2013, Phys.org network
Simple IMRT. Credit: Charlotte Coles
(Medical Xpress)—Research from the newly formed Cambridge Cancer Centre, a collaboration between the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cancer Research UK and others, could change how women with breast cancer are treated.
The study, by researchers from Addenbrooke's Hospital and the University of Cambridge led by Dr Charlotte Coles, found that women who received treatment with Intensity Modulated Radiation Therapy (IMRT) showed better overall cosmetic results compared to those given standard radiotherapy using only 2-dimensional (2D) planning. The study, which has been funded by the charity Breast Cancer Campaign and the NIHR Cambridge Biomedical Research Centre, was published in the Journal of Clinical Oncology.
For the study, the researchers analysed the radiotherapy treatment plans of 1145 patients with early breast cancer who had previously had breast-conserving surgery. Of these, 815 women (71%) were identified as potentially being able to benefit from IMRT, and were randomised to receive IMRT or standard radiotherapy. After five years from completion of radiotherapy, 654 women were followed up, 228 having received IMRT.
This study was specifically designed to look at possible improvement in the cosmetic result with IMRT. As expected, there was no difference in survival rates or chance of recurrence between the two treatments. Taking all cosmetic aspects into consideration, the overall cosmetic benefit was greater with IMRT, thanks to less damage to the breast tissue: 88% (197) of women had good or moderate cosmetic appearance after five years compared to 78% (179) who received the standard 2D radiotherapy. As well as halving the risk of poor cosmesis compared to standard 2D radiotherapy, IMRT also reduced the risk of developing marked skin telangiectasia, (dilated blood vessels appearing near the surface of the skin): 15% (35) compared to 24% (56) who received standard 2D radiotherapy.
Dr Charlotte Coles, a researcher at Addenbrooke's Hospital and Senior Faculty member of the Cambridge Cancer Centre, said: "We strongly believe that quality of life is important, as well as saving lives, and cosmetic results from radiotherapy have a real impact once treatment is finished. It's not trivial or a question of vanity. Poor cosmetic results can affect psychological wellbeing as well leaving a physical scar. It's a visible reminder to the woman that she has had cancer."
Radiotherapy aims to treat the whole breast with an even dose of radiation - too low a dose can lead to cancer coming back, and too high a dose can cause extensive damage to the skin and tissue, leading to visible side-effects that can also be painful. Unlike 2D breast radiotherapy, IMRT accounts for the shape of the breast in three dimensions so that the dose remains even across the breast.
In addition, IMRT has been shown to significantly reduce short term side effects (less weeping and peeling skin), compared to standard 2D breast radiotherapy.
All UK radiotherapy centres have the equipment to provide 3D radiotherapy and simple breast IMRT where appropriate. However, delivery of IMRT has been inconsistent. According to a recent audit one in five radiotherapy centres in the UK are not routinely using simple IMRT.
Baroness Delyth Morgan, Chief Executive of Breast Cancer Campaign said: "These practice changing results give out a clear message that where appropriate women must be given access to IMRT to get the best possible medical and cosmetic results from treatment. We know the technology is in place to deliver IMRT so let's not give women standard treatment if there is something better; women deserve more."
Professor Neil Burnet, Professor of Radiation Oncology at the University of Cambridge, said: "This is a landmark study, with major significance for women with breast cancer. It demonstrates the value to patients, and indeed society, of using modern radiotherapy technology."
Explore further: Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
Medical Xpress on facebook
Related Stories
Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
Apr 21, 2013
Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European ...
Breast conserving treatment with radiotherapy reduces risk of local recurrence
Sep 18, 2013
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcin ...
Studies confirm shorter radiotherapy course best option for women with breast cancer
Sep 18, 2013
The long-term results of the landmark START trials conclusively confirm that giving radiotherapy as a lower overall dose in fewer, higher doses over a shorter treatment time (hypofractionated) is at least as effective and ...
Despite hype, costly prostate cancer treatment offers little relief from side effects
Dec 13, 2012
Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a standard radiation ...
IMRT reduces risk of side effects in breast cancer patients
Mar 28, 2012
Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical Ra ...
Recommended for you
Functional disability high among newly diagnosed older breast cancer patients
7 hours ago
Many older women with newly diagnosed breast cancer have difficulty accomplishing daily tasks, and African-Americans seem to be disproportionately affected. Those are the findings of a new study published early online in ...
Eating, exercises improve diet after pharyngeal cancer Tx
Sep 20, 2013
(HealthDay)—Patients who maintain eating and a regimen of swallowing exercises during treatment for pharyngeal cancers have the highest rate of return to a regular diet following treatment, according to ...
Implications of very low risk prostate cancer assessed
Sep 20, 2013
(HealthDay)—The risk of adverse findings at surgery for men with very low risk (VLR) prostate cancer is significantly lower than for those with low risk (LR), according to research published in the October ...
Elvitegravir fixed combination in HIV: Lesser benefit for treatment-naive patients
Sep 20, 2013
The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (elvitegravir fixed combination, trade name: Stribild) has been approved in Germany since May 2013 for the treatment of adults infected ...
Watching tumors burst through a blood vessel
Sep 20, 2013
Cancer cells metastasize in several stages—first by invading surrounding tissue, then by infiltrating and spreading via the circulatory system. Some circulating cells work their way out of the vascular ...
Study provides big-picture view of how cancer cells are supported by normal cells in and near tumors
Sep 19, 2013
Investigators at Cold Spring Harbor Laboratory (CSHL) today report important progress in research aimed at finding ways to fight cancer by targeting the local environment in which tumors grow and from which ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment